Effect of Dan seven soft capsule adjuvant therapy on serum inflammatory factors , coagulation function and blood rheology indexes in patients with acute hemorrhagic cerebrovascular disease

Acute hemorrhagic cerebrovascular disease is a common emergency in clinic. Its incidence, mortality and disability rate are higher. In recent years epidemiological studies indicate that there is an upward trend in the occurrence of the disease, the main cause for cerebral vascular thrombosis and bleeding caused by rupture, serious illness caused disturbance of consciousness and limb paralysis, a serious threat to patient safety[1,2]. Edaravone is a kind of medicine used to treat cerebral hemorrhage and cerebral infarction at present. It has better effect on acute hemorrhagic cerebrovascular disease[3,4]. Studies have pointed out that the combination of traditional Chinese medicine treatment on the basis of conventional treatment can effectively improve the clinical symptoms of acute hemorrhagic cerebrovascular disease and reduce the incidence of complications[5,6]. The purpose of this study is to investigate the clinical efficacy of Dan seven soft capsule in the treatment of acute hemorrhagic cerebrovascular disease. The details are as follows.